Long-term anticoagulation with recombinant hirudin in a patient on left ventricular assist device support.
We report on a 24 year old man with a Novacor left ventricular assist device (LVAD) who underwent long-term treatment with intravenous recombinant hirudin due to a heparin induced thrombocytopenia (HIT II) after suffering from an ischemic stroke.
Tandler
R
R
Department of Cardio-Thoracic Surgery, Westfälische Wilhelms-Universität, Muenster, Germany.
Weyand
M
M
Schmid
C
C
Gradaus
R
R
Schmidt
C
C
Scheld
H H
HH
D000328:Adult; D000925:Anticoagulants / Q000008:administration & dosage*; D016027:Heart Transplantation; D006353:Heart-Assist Devices; D006493:Heparin / Q000009:adverse effects; D006629:Hirudins / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D011994:Recombinant Proteins / Q000008:administration & dosage; D020521:Stroke / Q000209:etiology; D013921:Thrombocytopenia / Q000139:chemically induced
D000925:Anticoagulants; D006629:Hirudins; D011994:Recombinant Proteins; D006493:Heparin